Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 14/20 | 0.58 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.57 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.57 |
| ▸ | CTSD | P07339 | 2/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30717683 | 0.96 | BACE1 (0.61) | BACE1BACE2KISS1RCTSD | |
| SCHEMBL6377734 | 0.94 | BACE1 (0.61) | BACE1BACE2KISS1RCTSDOPRM1 | |
| SCHEMBL6377728 | 0.94 | BACE1 (0.61) | BACE1BACE2KISS1RCTSDOPRM1 | |
| SCHEMBL29860570 | 0.91 | OPRM1 (0.60) | BACE1BACE2KISS1RCTSDOPRM1 | |
| SCHEMBL29772150 | 0.90 | BACE1 (0.62) | BACE1BACE2CTSDOPRM1OPRD1 | |
| SCHEMBL30974019 | 0.89 | BACE1 (0.57) | BACE1BACE2CTSDOPRM1OPRD1 | |
| SCHEMBL29385423 | 0.89 | LTA4H (0.58) | BACE1BACE2CTSD | |
| SCHEMBL29860042 | 0.88 | BACE1 (0.57) | BACE1BACE2CTSDOPRM1OPRD1 | |
| SCHEMBL30544311 | 0.86 | LTA4H (0.62) | BACE1BACE2KISS1ROPRM1OPRD1 | |
| SCHEMBL29384172 | 0.86 | LTA4H (0.62) | BACE1BACE2CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025002590-A1 | TISSUE MHC CLASS I IMMUNOPEPTIDE PATTERN DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST NON-SMALL CELL LUNG CANCER (NSCLC), IDENTIFICATION AND ISOLATION OF NSCLC SPECIFIC T CELLS IN HUMANS | UNIWERSYTET GDÁNSKI (PL) | 2025-01-02 | — | — | WO | claimed |
| EP-4484954-A1 | MHC CLASS I RESTRICTED IMMUNOPEPTIDE PATTERN FOR GENERATION OF ANTI-NSCLC VACCINES | Uniwersytet Gdanski (PL) | 2025-01-01 | — | — | EP | claimed |
| WO-2025002590-A1 | TISSUE MHC CLASS I IMMUNOPEPTIDE PATTERN DEDICATED FOR GENERATION OF ANTI-CANCER VACCINES AGAINST NON-SMALL CELL LUNG CANCER (NSCLC), IDENTIFICATION AND ISOLATION OF NSCLC SPECIFIC T CELLS IN HUMANS | UNIWERSYTET GDÁNSKI (PL) | 2025-01-02 | — | — | WO | disclosed |
| EP-4484954-A1 | MHC CLASS I RESTRICTED IMMUNOPEPTIDE PATTERN FOR GENERATION OF ANTI-NSCLC VACCINES | Uniwersytet Gdanski (PL) | 2025-01-01 | — | — | EP | disclosed |
| EP-4484955-A1 | METHOD FOR SCREENING OF EXTRACELLULAR TISSUE PEPTIDES IN MAMMALIAN TISSUE SAMPLES FOR HEALTH STATUS EVALUATION, DISEASE DIAGNOSTICS AND NEOANTIGEN DISCOVERY | Uniwersytet Gdanski (PL) | 2025-01-01 | — | — | EP | disclosed |